Keeping it Real With Investors  

Oleh:

Dipp, Michelle ; Westphal, Christoph ; Mirkin, Chad ; Baker, James ; Harper, Tim ; Harris, Charles

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 24 no. 2 (Feb. 2006), page 133-136.
Topik: investors; investors

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.4 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Nano biotech entrepreneurs learned the hard way that there is such a thing as pushing so called exotic or emerging technologies too hard with investors. Biotech entrepreneurs could learn a thing or two from their experience. One of the most enduring myths about the commercialization of biotech products is that venture capitalists (VCs) are interested in funding only the hottest new science and technologies. Equally widespread is the enduring (and mistaken) notion that biotech entrepreneurs benefit, in the long run, from hyperbole because it fuels the kind of media exposure that whats the appetite of investors...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali